Literature DB >> 11081171

Molecular pathogenesis of acromegaly.

M R Drange1, S Melmed.   

Abstract

Acromegaly is generally caused by growth hormone (GH) hypersecretion from a benign, monoclonal pituitary adenoma. As in other neoplastic conditions, pituitary tumor formation and dysregulated hormone secretion are most likely the ultimate result of a series of genetic alterations. A number of molecular and biochemical defects have been associated with pituitary tumorigenesis. Molecular events such as tumor suppressor gene inactivation and oncogene activation involved in pituitary tumor progression are examined. The role of hypothalamic regulatory hormones and hereditary syndromes involving acromegaly are also discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11081171     DOI: 10.1023/a:1009917920589

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  81 in total

1.  Abundance and state of phosphorylation of the retinoblastoma gene product in human pituitary tumors.

Authors:  M Woloschak; A Yu; J Xiao; K D Post
Journal:  Int J Cancer       Date:  1996-07-03       Impact factor: 7.396

2.  Frequent loss of the P16INK4a gene product in human pituitary tumors.

Authors:  M Woloschak; A Yu; J Xiao; K D Post
Journal:  Cancer Res       Date:  1996-06-01       Impact factor: 12.701

3.  Structure, expression, and function of human pituitary tumor-transforming gene (PTTG).

Authors:  X Zhang; G A Horwitz; T R Prezant; A Valentini; M Nakashima; M D Bronstein; S Melmed
Journal:  Mol Endocrinol       Date:  1999-01

Review 4.  Acromegaly.

Authors:  S Melmed
Journal:  N Engl J Med       Date:  1990-04-05       Impact factor: 91.245

Review 5.  Genetic basis of endocrine disease: pituitary tumor pathogenesis.

Authors:  I Shimon; S Melmed
Journal:  J Clin Endocrinol Metab       Date:  1997-06       Impact factor: 5.958

6.  Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours.

Authors:  S H Pearce; D Trump; C Wooding; M N Sheppard; R N Clayton; R V Thakker
Journal:  Clin Endocrinol (Oxf)       Date:  1996-08       Impact factor: 3.478

7.  Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.

Authors:  K Nakayama; N Ishida; M Shirane; A Inomata; T Inoue; N Shishido; I Horii; D Y Loh; K Nakayama
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

8.  Endocrine, biochemical, and morphological studies of a pituitary adenoma secreting growth hormone, thyrotropin (TSH), and alpha-subunit: evidence for secretion of TSH with increased bioactivity.

Authors:  P Beck-Peccoz; G Piscitelli; S Amr; M Ballabio; M Bassetti; G Giannattasio; A Spada; M Nissim; B D Weintraub; G Faglia
Journal:  J Clin Endocrinol Metab       Date:  1986-04       Impact factor: 5.958

9.  Dominant inheritance of the complex of myxomas, spotty pigmentation, and endocrine overactivity.

Authors:  J A Carney; L S Hruska; G D Beauchamp; H Gordon
Journal:  Mayo Clin Proc       Date:  1986-03       Impact factor: 7.616

10.  Familial acromegaly: a specific clinical entity--further evidence from the genetic study of a three-generation family.

Authors:  P Benlian; S Giraud; N Lahlou; M Roger; C Blin; C Holler; G Lenoir; J Sallandre; A Calender; G Turpin
Journal:  Eur J Endocrinol       Date:  1995-10       Impact factor: 6.664

View more
  3 in total

Review 1.  Growth hormone and its disorders.

Authors:  J Ayuk; M C Sheppard
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

2.  Simultaneous symptomatic Rathke's cleft cyst and GH secreting pituitary adenoma: a case report.

Authors:  Lucas J Bader; Kawanaa D Carter; Richard E Latchaw; William G Ellis; Jason A Wexler; Joseph C Watson
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

Review 3.  Multiple mechanisms of growth hormone-regulated gene transcription.

Authors:  Teresa I Ceseña; Tracy Xiao Cui; Graciela Piwien-Pilipuk; Julianne Kaplani; Anda-Alexandra Calinescu; Jeffrey S Huo; Jorge A Iñiguez-Lluhí; Roland Kwok; Jessica Schwartz
Journal:  Mol Genet Metab       Date:  2006-11-28       Impact factor: 4.797

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.